Navigation Links
Johns Hopkins neuroscientists win National Academy of Science Awards
Date:1/14/2013

Solomon H. Snyder, M.D., has won the National Academy of Sciences (NAS) Award in Neurosciences, and King-Wai Yau, Ph.D., has won the Alexander Hollaender Award in Biophysics, the NAS has announced. Both of these prestigious awards are offered only once every three years. Snyder and Yau will receive the awards on Sunday, April 28, during the Academy's 150th annual meeting.

"We are very proud to have two of our neuroscience faculty win awards from NAS in the same year," says Richard Huganir, Ph.D., director of the Solomon H. Snyder Department of Neuroscience. "Sol has contributed more to the field of molecular neuroscience than anyone in the world and is one of the luminaries in the field, and King's rigorous physiological and molecular approach has made him the preeminent biophysicist in vision research."

Snyder, a professor of neuroscience and former director of the eponymous Solomon H. Snyder Department of Neuroscience at the Institute for Basic Biomedical Sciences at the Johns Hopkins University School of Medicine, was recognized for groundbreaking discoveries ranging from the discovery of opiate receptors in the brain to proof that gases such as nitric oxide can serve as messengers between neurons. Many advances in molecular neuroscience have stemmed from Snyder's identification of receptors that neurons have for messenger molecules and some medications, a find which led to clarification of how these drugs work in the brain. His award comes with a $25,000 cash prize.

Yau, a professor of neuroscience and ophthalmology, was recognized for his work on vision. He discovered that two signaling molecules, calcium and cyclic GMP, convert light into electrical signals in the retina's rod and cone photoreceptor cells. This work led to a greater understanding of hereditary blinding diseases that affect rod and cone cells. By characterizing the light-response behaviors of a new type of photoreceptor cell in the retina, Yau found these cells affect circadian rhythms and other nonvisual cues in the brain.


'/>"/>

Contact: Vanessa McMains
vmcmain1@jhmi.edu
410-502-9410
Johns Hopkins Medicine
Source:Eurekalert  

Related medicine news :

1. US Drug Watchdog Now Urges Families Of Diabetics Diagnosed with Bladder Cancer To Call The Johnson Law Group If They Used the Diabetes Drug Called Actos
2. US Drug Watchdog Now Urges Users of Yaz or Yasmin Birth Control Pills Who Suffered A Life Threatening Medical Problem To Call The Johnson Law Group-Immediately
3. US Drug Watchdog Now Urges Family Members Mourning The Loss Of A Loved One Who Developed Bladder Cancer After Using The Diabetes Drug Actos To Call The Johnson Law Group
4. The US Drug Watchdog Now Urges Users Of The Birth Control Pills Yaz-Yasmin to Contact The Johnson Law Group For a Legal Review if They Developed Severe Medical Problems
5. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP
6. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
7. US Drug Watchdog Is Expanding Their Yaz-Yasmin Birth Control Pill Initiative and They Urge Victims to Contact the Johnson Law Group if They Had a Heart Attack or Stroke
8. Johns Hopkins receives funding for cholera vaccine initiative
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. A Serious Problem: Medical Malpractice Lawyers at Console & Hollawell React to Alarming Doctor Error Statistics from Johns Hopkins University Researchers
11. US Drug Watchdog Now Fears Most Women Never Heard About Yaz or Yasmin Birth Control Pill Side Effects and They Urge to Victims to Call the Johnson Law Group-Get Help Now
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Johns Hopkins neuroscientists win National Academy of Science Awards
(Date:2/12/2016)... ... February 12, 2016 , ... Nearly every health website ... health. These articles generally list between five and 15 foods that should be ... every one of these lists and believes that nutritious eye healthy foods are ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... Strategies for Health Plans and PBMs,” an upcoming Feb. 24 webinar that will ... access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi ...
(Date:2/12/2016)... ... 12, 2016 , ... Homeowners now have a next generation ... America’s leading brand of building products, has improved upon its industry-best array of ... version of the ColorView® Exterior Style and Color Selector. Created expressly for the ...
(Date:2/12/2016)... ... 2016 , ... US Sport Camps is pleased to announce the addition of ... serves as the host site and directing the camps is PGA Professional and 2008 ... camps in recent years around Des Moines and are fortunate to have such a ...
(Date:2/12/2016)... ... , ... A lot has been reported about the fitness routines of United ... and wellness resources most Americans could ever dream of having at their disposal. However, ... frenetic as the U.S. President. , In honor of President’s Day on Feb. ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12 2016  OMS Supply, a ... and medical practitioners, announced today the recent launching of ... visitors a variety of features that enhance the user ... surgery supplies. --> ... a fairly new company that started in early 2016, ...
(Date:2/12/2016)... 12 februari 2016 AAIPharma Services ... leverancier van productie en ontwikkeling op maat ... vandaag een uitbreiding aan van steriele vul- ... in Charleston, SC . ... meerdere recente investeringen. http://photos.prnewswire.com/prnh/20150806/256637LOGO ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: